KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Discontinued OperationsCash from Discontinued OperationsCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Depreciation & Amortization (CF) (2016 - 2026)

TherapeuticsMD filings provide 17 years of Depreciation & Amortization (CF) readings, the most recent being $94000.0 for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 1.05% to $94000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $383000.0, a 18.68% decrease, with the full-year FY2025 number at $384000.0, down 24.56% from a year prior.
  • Depreciation & Amortization (CF) hit $94000.0 in Q1 2026 for TherapeuticsMD, down from $97000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $637000.0 in Q4 2023 to a low of $27000.0 in Q1 2023.
  • Median Depreciation & Amortization (CF) over the past 5 years was $129000.0 (2023), compared with a mean of $182529.4.
  • Biggest five-year swings in Depreciation & Amortization (CF): plummeted 91.79% in 2023 and later skyrocketed 392.59% in 2024.
  • TherapeuticsMD's Depreciation & Amortization (CF) stood at $309000.0 in 2022, then surged by 106.15% to $637000.0 in 2023, then plummeted by 84.3% to $100000.0 in 2024, then decreased by 3.0% to $97000.0 in 2025, then fell by 3.09% to $94000.0 in 2026.
  • The last three reported values for Depreciation & Amortization (CF) were $94000.0 (Q1 2026), $97000.0 (Q4 2025), and $96000.0 (Q3 2025) per Business Quant data.